XNA-HUB, platform to boost therapeutic modified oligonucleotides

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

The project to create the XNA-HUB platform receives a significant boost thanks to PERTE funding. The platform will design therapeutic molecules based on modified nucleic acids using supercomputing tec...

Read more

An Easy and Rapid Test to Detect Infections Caused by Antibiotic-Resistant Bacteria in the Clinic

by ISGlobal - Instituto de Salud Global de Barcelona

A European multicentre study shows that the BL-DetecTool is highly sensitive in detecting two families of enzymes associated with antibiotic resistance directly from clinical samples

Read more

Confirman que el aceite de oliva virgen extra regula las funciones de una bacteria intestinal

by Fundación Andaluza para la Divulgación de la Innovación y el Conocimiento

Han demostrado en un estudio realizado con ratones que el tipo de grasas incluido en la dieta modula el comportamiento de los enterococos, un microorganismo frecuente en el tracto digestivo. Los resul...

Read more

Científicos de alto nivel aúnan esfuerzos para estudiar los aspectos más desconocidos del cerebro humano en un consorcio con la participación del CBC de la UPF

by UPF - Universitat Pompeu Fabra

Con esta finalidad, se ha constituido el consorcio de investigadores de alto nivel BRADY (Brain Dynamics), en el que participa el Centre for Brain and Cognition (CBC) de la UPF. Este consorcio coordi...

Read more

GREAT DISCOVERIES IN BIOSCIENCES IN 2023

by Abyntek

2023 in biomedical research has been full of incredible advances that bring us, step by step, closer to the future. From the production of green fertilisers that reduce their impact on the environment...

Read more

Palobiofarma closes a €7M round with the participation of Inveready, Sodena and the Promotor team

by Palobiofarma

The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...

Read more

Researchers identify a new mechanism that could improve the efficiency of diabetes treatments

by Universitat de Barcelona

The study reveals that GDF15 inhibits glucose synthesis in the liver. This pathway plays a decisive role in the generation of hyperglycaemia (increased blood glucose levels) in patients with type 2 di...

Read more

Exploratory analysis from the phase III INTRIGUE study points to the promise of liquid biopsy in guiding patient selection for targeted therapy and personalized medicine in advanced GIST

by VHIO

Results of exploratory research from the open-label phase III INTRIGUE clinical trial demonstrate the potential utility of circulating tumor DNA (ctDNA) next-generation sequencing (NGS)-based analysis...

Read more

New experimental drug to control hypertension

by Universidad Rey Juan Carlos

An international research team, led by the Rey Juan Carlos University, has demonstrated the beneficial effect of a new compound derived from melatonin for the treatment of cardiovascular disorders ass...

Read more

El impulso de pruebas genéticas mejora el diagnóstico de las causas de la epilepsia

by Hospital Universitari de Bellvitge

Las Unidades de Epilepsia y de Genética Clínica del Hospital Universitario de Bellvitge han puesto en marcha estudios genéticos multidisciplinarios para identificar la causa de la epilepsia, un tra...

Read more

New tool for estimating population genetic risk to comune diseases

by IRB Lleida. Institut de Recerca Biomèdica

It has been developed a bioinformatics tool for estimating the genetic risk of suffering common diseases such as diabetes, heart attacks or cancer in a certain population.

Read more

I3PT, CONNECTA Therapeutics, CRG and IMIM receive 2,7 million from the Ministry of Science and Innovation to start Phase IIa of the drug CTH120 for fragile X syndrome

by Instituto de Investigación e Innovación Parc Taulí

The Phase IIa study will evaluate the efficacy of CTH120 as an innovative therapy in adult patients with FXS, the most common form of inherited intellectual disability without a specific treatment

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream